帕金森病中的冲动控制障碍:风险因素,病原和药理管理的概述
Federico Carbone1, Atbin Djamshidian2
1Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria.
CNS drugs
|April 13, 2024
概括
冲动控制障碍,通常由帕金森病药物如多巴胺激动剂引发,需要谨慎管理. 早期检测和多学科方法是平衡治疗和预防成行为的关键.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 冲动控制障碍 (ICD) 是帕金森病 (PD) 中常见的,药物诱导的成行为.
- 多巴胺激动剂 (例如pramipexole,ropinirole,rotigotine) 是PD患者常见的ICD触发剂.
研究的目的:
- 提供关于帕金森病ICDs当前知识的全面概述.
- 总结一下患病率,临床特征,风险因素和PD中ICD的潜在机制.
- 讨论最近在诊断和管理策略的进展,在PD的ICDs.
主要方法:
- 这项研究是对帕金森病中冲动控制障碍的现有文献进行叙事审查.
- 综合了有关患病率,临床表现,风险因素和病因机制的信息.
- 审查了当前诊断和治疗方面的进展.
主要成果:
- 冲动控制障碍表现为各种临床特征,并具有可识别的风险因素和潜在机制.
- 管理策略包括早期检测和多学科方法.
- 治疗调整可能包括优化多巴氨基疗法,管理神经精神症状,并考虑先进的干预措施,如利沃多巴,阿波莫尔芬或深度大脑刺激.
结论:
- 在帕金森病中有效管理ICD需要早期识别和个性化,多学科的战略.
- 仔细调整多巴胺疗法,特别是多巴胺激动剂,至关重要.
- 将运动症状控制与降低多巴胺类药物的平衡,对于患有ICD的PD患者的良好长期结果至关重要.
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Attention-Deficit/Hyperactivity Disorder
57
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
57
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
606
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
606
Obsessive-Compulsive Disorder
125
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
125
Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124


